Open AccessP372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB
Author(s) -
Macaron W.,
Jabbour E.,
Konopleva M.,
Ravandi F.,
Jain N.,
Issa G.,
Kadia T.,
Sasaki K.,
Kebriaei P.,
Yilmaz M.,
Thompson P.,
Takahashi K.,
Abbas H.,
Wierda W.,
Garris R.,
Kantarjian H.,
Short N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844376.80277.de
Subject(s) - blinatumomab , medicine , minimal residual disease , salvage therapy , refractory (planetary science) , gastroenterology , oncology , lymphoblastic leukemia , leukemia , chemotherapy , physics , astrobiology